- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04111874
Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD
December 8, 2024 updated by: Eric A Storch, Baylor College of Medicine
This study implements an anxiety-focused, parent-led, therapist-assisted cognitive behavioral teletherapy for parents of youth with ASD and anxiety.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Anxiety disorders affect 50-80% of children with autism spectrum disorder (ASD) and are associated with significant life impairment and worsening trajectory without treatment.
The most effective psychotherapy for anxiety in youth with and without ASD is cognitive behavioral therapy (CBT), but many families are not able to access CBT due to the cost, practicalities of attending treatment sessions, and limited availability of trained therapists.
Alternative models of service delivery are greatly needed, with particular promise of parent-led therapist-assisted (PLTA) models and telehealth delivery formats.
Parents may benefit from additional information regarding how to optimize the delivery of CBT for youths with ASD given the potential impact of ASD symptomology on core CBT skills.
Thus, this project aims to improve access to anxiety-focused Parent-Led Therapist-Assisted CBT for parents of youth with ASD.
Parent-led low-intensity treatment models can improve accessibility, efficiency, and mental health treatment cost.
Lower intensity treatment models provide a treatment option that is less costly and burdensome for parents; it is understood that some individuals will respond to the first step and others will require additional treatment to achieve anxiety reduction.
However, understanding how many families, and which families, can benefit from a lower intensity model has dramatic benefits for improving access, allocating more intensive services for those most in need, and reducing barriers (e.g., distance).
Thus, this study will examine the effectiveness of two anxiety-focused PTLA CBT telehealth models: 1) low-intensity therapist assistance (LTA) and 2) standard therapist assistance (STA).
Overall, this study will provide important information regarding the potential benefits of two different approaches to parent-led interventions for youth with ASD and anxiety when delivered via telehealth.
Study Type
Interventional
Enrollment (Actual)
87
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 13 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Child is between the ages 7-13 years at consent/assent.
- The child meets criteria for ASD.
- The child meets criteria for clinically significant anxiety and/or OCD symptoms.
- Anxiety and/or OCD is the primary presenting problem.
- One parent/guardian is able and willing to participate.
- The child has a Full Scale and Verbal Comprehension Intelligence Quotient >70.
- The child is able to communicate verbally.
- Participants must reside in Texas and parents must be in the state of Texas when taking calls.
Exclusion Criteria:
- The child has a diagnosis of lifetime DSM-5 bipolar disorder, psychotic disorder, and/or intellectual disability.
- The child has severe current suicidal/homicidal ideation and/or self-injury requiring medical intervention.
- The child is receiving concurrent psychotherapy for anxiety.
- Initiation of a psychotropic medication less than 4 weeks prior to study enrollment or a stimulant/psychoactive medication less than 2 weeks prior to study enrollment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low-Intensity Therapist Assistance (LTA)
Parents will receive four 30-minute supportive video calls with a therapist over the 12 weeks of treatment.
|
Participating families will receive a copy of the book 'Helping Your Anxious Child, 2nd Edition', as well as the companion parent and child workbooks, to use at home and in session with the therapist.
During each of the four videoconferencing sessions, therapists will serve to provide encouragement and support as the parent works through the program independently.
|
|
Active Comparator: Standard Therapist Assistance (STA)
Parents will receive ten 60-minute supportive video calls with a therapist over the 12 weeks of treatment.
|
Participating families will also receive a copy of the book 'Helping Your Anxious Child, 2nd Edition', as well as the companion parent and child workbooks, to use at home and in session with the therapist.
During each of the ten videoconferencing sessions, therapists will guide the parent through the implementation of the program, including explaining materials, assisting to develop planned therapy activities with the child, and problem-solving as needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-item Pediatric Anxiety Rating Scale
Time Frame: Baseline (before treatment), post-treatment (on average 12 weeks), 3 month follow up; Post-treatment scores reported.
|
Clinician rated child anxiety severity throughout the past week.
Each item is scored on a 0 to 5 scale (higher scores correspond to greater severity), yielding a total between 0 and 30.
|
Baseline (before treatment), post-treatment (on average 12 weeks), 3 month follow up; Post-treatment scores reported.
|
|
Clinical Global Impression-Improvement
Time Frame: Each treatment session, post-treatment (on average 12 weeks), 3 month follow up; Post-treatment scores reported.
|
Clinician rated child psychopathology improvement since initial rating.
A single item is scored 0-6 (0 = very much worse; 6= very much improved).
|
Each treatment session, post-treatment (on average 12 weeks), 3 month follow up; Post-treatment scores reported.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Global Impression-Severity
Time Frame: Baseline (before treatment), Each treatment session, post-treatment (on average 12 weeks), 3 month follow up; Post-treatment scores reported.
|
Clinician rated child psychopathology severity rating.
A single item is scored 0-6 (0= no illness; 6= extremely severe symptoms).
|
Baseline (before treatment), Each treatment session, post-treatment (on average 12 weeks), 3 month follow up; Post-treatment scores reported.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 30, 2019
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
September 30, 2019
First Submitted That Met QC Criteria
September 30, 2019
First Posted (Actual)
October 1, 2019
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 8, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H45203
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obsessive-Compulsive Disorder
-
Shanghai Pudong New Area Mental Health Center,...RecruitingObsessive Compulsive Disorder (OCD) | Obsessive - Compulsive DisorderChina
-
National Institute of Mental Health, Czech RepublicRecruitingObsessive-compulsive DisorderCzechia
-
ASST Fatebenefratelli SaccoFondazione IRCCS San Gerardo dei Tintori; Istittuo ricerca carattere Sceintifico...Enrolling by invitationObsessive - Compulsive DisorderItaly
-
Assiut UniversityNot yet recruitingSubstance Use | Substance Abuse Disorder | Obsessive Compulsive Disorder (OCD) | Obsessive Compulsive Behavior | Obsessive - Compulsive Disorder
-
Anne Katrine PagsbergCopenhagen Trial Unit, Center for Clinical Intervention Research; Danish Research...Active, not recruitingObsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceDenmark
-
Shanghai Mental Health CenterNot yet recruitingObsessive - Compulsive DisorderChina
-
Adam FrankRecruitingObsessive - Compulsive DisorderUnited States
-
Mehmet Emrah KaradereGoztepe Prof Dr Suleyman Yalcın City HospitalRecruitingOCD | Obsessive - Compulsive DisorderTurkey (Türkiye)
-
Taipei Veterans General Hospital, TaiwanRecruitingObsessive-Compulsive Disorder (OCD)Taiwan
-
VU University of AmsterdamUniversity of Bern; Stockholm University; Thomas More University of Applied SciencesNot yet recruitingObsessive Compulsive Disorder (OCD)Sweden, Belgium, Netherlands, Switzerland
Clinical Trials on Cognitive Behavioral Teletherapy LTA
-
University of Texas Southwestern Medical CenterNational Institute of Mental Health (NIMH)CompletedDepressive Disorder | Depression | Depressive Symptoms | Depressive EpisodeUnited States
-
Oregon Research InstituteNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
UConn HealthCompletedObsessive-Compulsive DisorderUnited States
-
Far Eastern Memorial HospitalUnknownDepression | Inflammation | InsomniaTaiwan
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingDepressionUnited States